Chemistry: molecular biology and microbiology – Process of mutation – cell fusion – or genetic modification – Introduction of a polynucleotide molecule into or...
Patent
1997-09-25
2000-09-12
Yucel, Remy
Chemistry: molecular biology and microbiology
Process of mutation, cell fusion, or genetic modification
Introduction of a polynucleotide molecule into or...
435325, 435352, C12N 506
Patent
active
061176818
ABSTRACT:
The present invention relates to a retroviral vector system comprising a packaging cell line that synthesize the core and enzymatic proteins of MLV virus from one or more gag and pol containing constructs and the envelope of MMTV virus from the same or an independent env containing construct, and to pseudotyped retroviral particles produced by culturing said retroviral vector system transfected with a MLV based retroviral vector, and isolation of said pseudotyped retroviral particles.
REFERENCES:
patent: 4861719 (1989-08-01), Miller
patent: 5278056 (1994-01-01), Bank et al.
patent: 5449614 (1995-09-01), Danos et al.
patent: 5658775 (1997-08-01), Gilboa
Emi et al. Journal of Virology. vol. 65, No. 3, pp. 1202-1207, Mar. 1991.
Burns et al. Proceedings of the National Academy of Sciences, USA. vol. 90, pp. 8033-8037, Sep. 1993.
Hopkins, N. Proceedings of the National Academy of Sciences, USA. vol. 90, pp. 8759-8760, Oct. 1993.
Schochetman et al. Virology. vol. 97, pp. 342-353, 1979.
Salmons, B. et al., "Construction of Retroviral Vectors for Targeted Delivery and Expression of Therapeutic Genes," Leukemia, 9, Suppl. 1:S53-S60, (1995).
Weiss, R.A., Chapter 1: "Cellular Receptors and Viral Glycoproteins Involved in Retrovirus Entry," The Retroviridae, vol. 2 pp. 1-54, (1993).
Gunzburg, W.H. and Salmons, B., "Factors controlling the expression of mouse mammary tumour virus," Biochem. J., 283:625-632 (1992).
Takeuchi, Y. et al., "Retroviral Pseudotypes Produced by Rescue of a Moloney Murine Leukemia Virus Vector by C-type, but Not D-type, Retroviruses," Virol., 186:792-794, (1992).
Vile, R.G., et al., "A Murine Cell Line Producing HTLV-1 Pseudotype Virions Carrying a Selectable Marker Gene," Virol., 180:420-424, (1991).
Wilson, C., et al., "Formation of Infectious Hybrid Virions with Gibbon Ape Leukemia Virus and Human T-Cell Leukemia Virus Retroviral Envelope Glycoproteins and the gag and pol Proteins of Moloney Murine Leukemia Virus," J. Virol., 63(5):2374-2378, (1989).
Markowitz, D.A., et al., "A Safe Packaging Line for Gene Transfer: Separating Viral Genes on Two Different Plasmids," J. Virol., 62(4):1120-1124, (1988).
Markowitz, D., et al., "Construction and Use of a Safe and Efficient Amphotropic Packaging Cell Line," Virol., 167:400-406, (1988).
Emi, N., et al., "Pseudotype Formation of Retrovirus Vectors Containing the Glycoprotein of Vesicular Stomatitis Virus," J. Cell Biochem., Suppl. D408:367, (1990).
Yang, Y., et al., "Development and Characterization of a Packaging Cell Line that Generates Novel Retroviral Vectors with Broad Mammalian Host Cell Range," Blood, 82(10:Suppl. 1185):300A, (1993).
Yang, Y., et al., "Vesicular Stomatitis Virus (VSV) Pseudotyped Murine Retrovirus Mediates Gene Transfer into Human Hematopoietic Cells", Blood, 84:(10 Suppl. 1417):358a, (1994).
Yang, Y., et al., "Inducible, High-Level Production of Infectious Murine Leukemia Retroviral Vector Particles Pseudotyped with Vesicular Stomatitis Virus G Enevelope Protein," Human Gene Therapy, 6:1203-1213, (1995).
Lefkowitz, E.J., et al., "Complementation of a Vesicular Stomatitis Virus Glycoprotein G Mutant with Wild-Type Protein Expressed from either a Bovine Papilloma Virus or a Vaccinia Virus Vector System," Virol., 178:373-383, (1990).
Burns, J.C., et al., "Pantropic Retroviral Vector-Mediated Gene Transfer, Integration, and Expression in Cultured Newt Limb Cells," Develop. Biol., 165:285-289, (1994).
Emi, N., et al., "Pseudotype Formation of Murine Leukemia Virus with the G Protein of Vesicular Stomatitis Virus," J. Virol., 65(3):1202-1207, (1991).
Rolls, M.M., et al., "Novel Infectious Particles Generated by Expression of the Vesicular Stomatitis Virus Glycoprotein from a Self-Replicating RNA," Cell, 79:497-506, (1994).
Yee, J.-K., et al., "Generation of High-Titer Pseudotyped Retroviral Vectors with Very Broad Host Range," Meth. Cell Biol., 43:99-112, (1994).
Lin, S. et al., "Integration and Germ-Line Transmission of a Pseudotyped Retroviral Vector in Zebrafish," Science, 265:666-669, (1994).
Burns, J.C. et al., "Vesicular Stomatitis Virus G. Glycoprotein Pseudotyped Retroviral Vectors: Concentration to Very High Titer and Efficient Gene Transfer into Mammalian and Nonmammalian Cells," Proc. Natl. Acad. Sci. USA, 90:8033-8037 (1993).
Yee, J.-K., et al., "A General Method for the Generation of High-Titer, Pantropic Retroviral Vectors: Highly Efficient Infection of Primary Hepatocytes," Proc. Natl. Acad. Sci. USA, 91:9564-9568, (1994).
Miller, A.D., et al., "Use of Retroviral Vector5 for Gene Transfer and Expression," Meth. Enzymol., 271:581-599, (1993).
Ory, D.S., et al., "A stable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatits virus G pseudotyped," Proc. Natl. Acad. Sci. USA, 93:11400-11406, (1996).
Baumann Jorg G.
Salmons Brian
Bavarian Nordic Research Inst. A/S
GSF-Gessellschaft fur Umwelt und Gesundheit GmbH
Yucel Remy
LandOfFree
Pseudotyped retroviral particles does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pseudotyped retroviral particles, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pseudotyped retroviral particles will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-95233